HHS Freezes COVID Vaccine Contract, Demands Transparency Now
Submitted by MAGA
Posted 1 day ago
**BREAKING: HHS Halts COVID-19 Vaccine Contract Amid Calls for Transparency**
In a stunning move, the Department of Health and Human Services (HHS) has paused a multimillion-dollar contract to develop a new COVID-19 vaccine, a decision underscoring a commitment to pandemic preparedness over hasty rollouts.
This decisive action was taken by Secretary of Health and Human Services, Robert F. Kennedy Jr., and it has the potential to reshape the way vaccine development is approached in the future.
Kennedy issued a 90-day stop work order on February 21 regarding the contract with Vaxart Inc., a U.S.-based biotech firm focused on creating an oral vaccine.
Initially, 10,000 participants were set to begin clinical trials, but this abrupt halt reflects growing concerns about vaccine efficacy and safety, issues that have been overlooked by previous administrations.
Kennedy emphasized the need for rigorous oversight, stating, “Four years of the Biden administration’s failed oversight have made it necessary to review agreements for vaccine production, including Vaxart’s.”
The review process will take place over the next 90 days, during which Kennedy and health officials will evaluate the investigative findings before determining the next steps.
This decision marks a notable shift from the previous administration's approach, particularly in light of the $4.7 billion Project NextGen program launched by the Biden administration, which funded Vaxart's vaccine development through a $460 million agreement.
Critics of the Biden administration may see this pause as a necessary correction, given that numerous studies are now emerging questioning the overarching efficacy and safety of COVID-19 vaccines that were rushed to market under previous guidelines.
Notably, this decision to reassess vaccine production aligns with a broader push for “radical transparency” in health policies, allowing Americans to make informed decisions regarding their health.
Kennedy's commitment to informed consent and scientific integrity stands in stark contrast to the previous administration's vaccine mandates, which often faced backlash for infringing on personal freedom.
In the wake of this pause, other former health officials are speaking out, highlighting the failures of pandemic responses under the Biden administration and the need for a more thorough analysis of health interventions.
As the world watches, this pivotal moment in vaccine oversight could signal a transformation in how health authorities approach future public health emergencies, making it clear that accountability and transparency should be the cornerstones of our health policies moving forward.
In a time where vaccine mandates have raised significant concerns, this development may resonate with many Americans who value individual rights and the importance of scientific rigor in medical recommendations.
The repercussions of this pause will undoubtedly extend beyond the immediate implications for Vaxart, potentially reshaping the entire landscape of public health governance in America.
Sources:
theepochtimes.com
amgreatness.com
trendingpoliticsnews.com
In a stunning move, the Department of Health and Human Services (HHS) has paused a multimillion-dollar contract to develop a new COVID-19 vaccine, a decision underscoring a commitment to pandemic preparedness over hasty rollouts.
This decisive action was taken by Secretary of Health and Human Services, Robert F. Kennedy Jr., and it has the potential to reshape the way vaccine development is approached in the future.
Kennedy issued a 90-day stop work order on February 21 regarding the contract with Vaxart Inc., a U.S.-based biotech firm focused on creating an oral vaccine.
Initially, 10,000 participants were set to begin clinical trials, but this abrupt halt reflects growing concerns about vaccine efficacy and safety, issues that have been overlooked by previous administrations.
Kennedy emphasized the need for rigorous oversight, stating, “Four years of the Biden administration’s failed oversight have made it necessary to review agreements for vaccine production, including Vaxart’s.”
The review process will take place over the next 90 days, during which Kennedy and health officials will evaluate the investigative findings before determining the next steps.
This decision marks a notable shift from the previous administration's approach, particularly in light of the $4.7 billion Project NextGen program launched by the Biden administration, which funded Vaxart's vaccine development through a $460 million agreement.
Critics of the Biden administration may see this pause as a necessary correction, given that numerous studies are now emerging questioning the overarching efficacy and safety of COVID-19 vaccines that were rushed to market under previous guidelines.
Notably, this decision to reassess vaccine production aligns with a broader push for “radical transparency” in health policies, allowing Americans to make informed decisions regarding their health.
Kennedy's commitment to informed consent and scientific integrity stands in stark contrast to the previous administration's vaccine mandates, which often faced backlash for infringing on personal freedom.
In the wake of this pause, other former health officials are speaking out, highlighting the failures of pandemic responses under the Biden administration and the need for a more thorough analysis of health interventions.
As the world watches, this pivotal moment in vaccine oversight could signal a transformation in how health authorities approach future public health emergencies, making it clear that accountability and transparency should be the cornerstones of our health policies moving forward.
In a time where vaccine mandates have raised significant concerns, this development may resonate with many Americans who value individual rights and the importance of scientific rigor in medical recommendations.
The repercussions of this pause will undoubtedly extend beyond the immediate implications for Vaxart, potentially reshaping the entire landscape of public health governance in America.
Sources:
theepochtimes.com
amgreatness.com
trendingpoliticsnews.com
Latest News